Dor Biopharma, Inc.
Records under this name other than patents Dor Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Dor Biopharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,535,650 | Stabilized reverse micelle compositions and uses thereof Formerly held Term ended Term ended Sep 18, 2025 · USPTO record | Term ended | Term ended Sep 18, 2025 | USPTO record |
| US 8,263,582 | Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids Formerly held Term ended Term ended Mar 15, 2022 · USPTO record | Term ended | Term ended Mar 15, 2022 | USPTO record |
| US 7,323,471 | Topical azathioprine for the treatment of oral autoimmune diseases Formerly held Lapsed on the fee record Ended Jan 29, 2012 · USPTO record | Lapsed on the fee record | Ended Jan 29, 2012 | USPTO record |
| US 6,187,335 | Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom Lapsed on the fee record Ended Feb 13, 2009 · USPTO record | Lapsed on the fee record | Ended Feb 13, 2009 | USPTO record |